AIML (formally ACVT) has been working with LBT Innovations, a South Australian medical device company, for more than 5 years on a new form of medical device to automate the reading of Agar plates.
A ten-week pivotal clinical trial at TriCore Reference Laboratories in New Mexico during July and August 2015 tested APAS against a panel of microbiologists. C
Lusia Guthrie was interviewed by Amanda Vanstone about our collaboration on the ABC’s Counterpoint program.
Medical technology company LBT Innovations Limited (ASX: LBT) has signed an agreement with the Switzerland-based laboratory instrumentation company, Hettich AG Switzerland, to finalise a partnership to complete the development and commercialisation of LBT’s Automated Plate Assessment System (APAS®).